IDSA 2011: Dr. Christian Loucq on Successful Initial Results of a Malaria Vaccine Trial [Podcast]
Loucq discusses initial results of a trial of the experimental malaria vaccine RTS,S in which risk of infection was cut in half.
BOSTON, MA—In this interview at the annual conference of the Infectious Diseases Society of America, Christian Loucq, MD, director of the PATH Malaria Vaccine Initiative, discusses promising initial results of a Phase III trial of the experimental malaria vaccine RTS,S.
Related Videos
Related Content
